Integra's CUSA Clarity Gains Cardiac Clearance

Integra LifeSciences stock surged after FDA cleared CUSA Clarity for cardiac surgeries, expanding its use to valve replacement and repair. This approval marks a significant expansion of the ultrasonic surgical aspirator systems capabilities, with Integra set to showcase the device at the American Association for Thoracic Surgeon Mitral Valve Conclave in December. This development is expected to boost Integras presence in the cardiac surgery market and open new revenue streams.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.